Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
How to dose GLOW on a weekly grid
Preliminary studies on the effect of moderate physical activity on blood levels of glutathione
Targeted Nanoparticles for Drug Delivery Across the BloodBrain Barrier in Early and Late Stages of Alzheimer's Disease: A Review
Scientists are working to better understand how your immune system changes during pregnancy
352 Elacestrant has emerged as the first FDA-approved oral estrogen receptor antagonist for ESR1 -mutant patients, owing to substantial improvements in progression-free survival (PFS) observed during the EMERALD phase 3 trial in the ESR1 -mutant population
US$ 26.54
US$ 22.52
US$ 26.14
